Kelly Financial Services LLC Axsome Therapeutics, Inc. Transaction History

Kelly Financial Services LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Jul 17, 2024	SELL	$41.2 - $101.31 $1,689 - $4,153	-41 Closed	0 $0
Q4 2019 Jul 17, 2024	BUY	$16.71 - $106.24 $685 - $4,355	41 New	41 $4.24 Million
Q3 2019 Jul 17, 2024	SELL	$20.24 - $29.16 $3,238 - $4,665	-160 Closed	0 $0
Q2 2019 Jul 17, 2024	BUY	$13.46 - $25.75 $2,153 - $4,120	160 New	160 $4.12 Million

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.73B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Kelly Financial Services LLC with notifications on news.